Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777418

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777418

Pediatric Cardiac Tumor Diagnostics

PUBLISHED:
PAGES: 376 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Pediatric Cardiac Tumor Diagnostics Market to Reach US$946.1 Million by 2030

The global market for Pediatric Cardiac Tumor Diagnostics estimated at US$662.7 Million in the year 2024, is expected to reach US$946.1 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Primary Cardiac Tumors, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$566.9 Million by the end of the analysis period. Growth in the Secondary Cardiac Tumors segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$180.6 Million While China is Forecast to Grow at 9.4% CAGR

The Pediatric Cardiac Tumor Diagnostics market in the U.S. is estimated at US$180.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$191.0 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Pediatric Cardiac Tumor Diagnostics Market - Key Trends & Drivers Summarized

How Is Rare Becoming Relevant? The Surging Focus on Early Diagnosis of Pediatric Cardiac Tumors

Pediatric cardiac tumors are among the rarest but most serious cardiovascular abnormalities observed in infants and children, often presenting significant diagnostic and treatment challenges. While the incidence of primary cardiac tumors in the pediatric population is estimated at less than 0.2%, the implications of delayed or missed diagnosis can be life-threatening, leading to arrhythmias, heart failure, or sudden cardiac death. Historically, diagnosis was typically incidental, discovered during investigations for unrelated symptoms or during autopsies. However, there is now a clear shift towards early, targeted diagnostics driven by the expansion of pediatric cardiology programs and increased clinician awareness. Advances in fetal and neonatal echocardiography are enabling the detection of cardiac tumors even before birth, especially those with large sizes or those obstructing cardiac function. Rhabdomyomas, fibromas, and myxomas are the most common benign tumors found in children, each presenting distinct diagnostic profiles that necessitate a highly tailored approach to imaging and interpretation. In the clinical setting, pediatricians and cardiologists are increasingly trained to recognize subtle signs-such as murmurs, cyanosis, or recurrent syncope-that may warrant deeper investigation. The growing integration of genetic counseling, particularly in syndromes like tuberous sclerosis complex, which is frequently associated with cardiac rhabdomyomas, also adds a proactive layer to early diagnosis. As survival rates improve and clinical surveillance becomes more robust, pediatric cardiac tumor diagnostics are transitioning from a reactive to a preventative domain, underscoring their rising relevance in pediatric healthcare systems globally.

Why Is Imaging at the Heart of Progress? Exploring the Technological Revolution in Pediatric Cardiac Diagnostics

The technological landscape for pediatric cardiac tumor diagnostics has evolved dramatically, with non-invasive imaging modalities taking center stage in both detection and monitoring. Echocardiography remains the cornerstone of initial assessment due to its safety, portability, and high-resolution real-time imaging capabilities. Innovations in 3D echocardiography and Doppler modalities are enhancing diagnostic accuracy by providing detailed anatomical and functional insights into tumor size, location, and hemodynamic impact. Cardiac magnetic resonance imaging (MRI) has emerged as a critical adjunct, offering superior tissue characterization, particularly for differentiating between tumor types and distinguishing them from thrombi or other masses. Advanced sequences, such as T1 and T2 mapping and late gadolinium enhancement, are enabling more precise delineation of tumor margins and infiltration, crucial for surgical planning and risk assessment. Additionally, cardiac computed tomography (CT), despite its radiation exposure, is increasingly used in complex or ambiguous cases where rapid 3D visualization of tumor morphology and coronary anatomy is required. The incorporation of artificial intelligence and machine learning algorithms into image analysis is opening new avenues for pattern recognition and diagnostic standardization, particularly in tertiary pediatric centers. Emerging modalities such as PET-MRI fusion imaging and contrast-enhanced ultrasound are also being explored to bridge the gap between anatomical and metabolic assessment. These technological advances are not only improving diagnostic confidence but are also reducing the need for invasive procedures like cardiac catheterization or biopsy in many cases. As diagnostic imaging becomes more refined and digitally integrated, the role of radiologists and pediatric cardiologists is evolving into a more collaborative, data-driven partnership aimed at timely and precise diagnosis of these life-impacting tumors.

Is Multidisciplinary Collaboration Reshaping the Diagnostic Workflow for Pediatric Cardiac Tumors?

The complex nature of pediatric cardiac tumors has made multidisciplinary collaboration essential in streamlining diagnosis, risk stratification, and care pathways. A pediatric cardiac tumor diagnosis often triggers the coordinated involvement of pediatric cardiologists, cardiac surgeons, oncologists, radiologists, pathologists, geneticists, and critical care specialists. This team-based approach is becoming the standard of care at leading pediatric hospitals and specialized heart institutes. Tumor boards comprising these specialties are increasingly convened to review imaging findings, evaluate surgical feasibility, and decide on follow-up protocols. Furthermore, genetic profiling is being integrated into diagnostics to identify syndromic associations, inherited mutations, and potential recurrence risks, particularly in conditions like Carney complex or Gorlin syndrome. As tumor biopsies are often contraindicated due to their invasive nature and associated risks, histopathological insights are typically inferred from imaging and clinical data, making collaborative diagnostic interpretation all the more crucial. The rise of pediatric cardio-oncology as a sub-discipline is further highlighting the need for shared decision-making across specialties. Telemedicine platforms and digital case-sharing tools are also enabling remote participation of expert panels in real time, particularly for rare or ambiguous cases requiring second opinions. Parental counseling and psychosocial support are increasingly integrated into the diagnostic journey, recognizing the emotional impact of cardiac tumor detection in children. This systemic shift toward multidisciplinary care is not only improving diagnostic timelines and accuracy but also fostering individualized treatment strategies that optimize both survival and quality of life. With growing institutional emphasis on care integration, diagnostic workflows for pediatric cardiac tumors are becoming more cohesive, coordinated, and patient-centered.

The Growth in the Pediatric Cardiac Tumor Diagnostics Market Is Driven by Several Factors…

The growth in the pediatric cardiac tumor diagnostics market is driven by several factors centered on diagnostic innovation, expanding clinical use cases, and evolving consumer expectations. Technological advances in pediatric cardiac imaging-particularly the widespread adoption of 3D echocardiography, high-field cardiac MRI, and hybrid imaging techniques-are significantly improving early detection rates and diagnostic precision, thereby expanding market penetration. From an end-use perspective, the growing prevalence of pediatric specialty hospitals, fetal cardiology programs, and pediatric oncology centers is increasing demand for high-resolution and multiparametric diagnostic tools. Another key driver is the rising integration of genetic and molecular diagnostics into cardiology workflows, enabling proactive identification of tumor predispositions and associated syndromes. Healthcare providers are also investing heavily in cloud-based image management systems and AI-enhanced analytics platforms, which support collaborative diagnostics, reduce interpretation errors, and streamline reporting across multisite healthcare networks. Increasing clinician awareness and continuous education programs on rare pediatric cardiac presentations are boosting the frequency and accuracy of referrals for diagnostic imaging. Furthermore, the acceleration of newborn and prenatal screening initiatives is bringing cardiac tumors into the diagnostic spotlight at much earlier stages, leading to more favorable intervention windows. On the consumer front, parents are becoming more engaged in pediatric health decisions and increasingly expect swift, non-invasive, and accurate diagnostic options-a trend that is shaping procurement priorities and patient pathway designs. Additionally, rising investments in pediatric research and international collaborations are promoting the development of evidence-based diagnostic guidelines, which in turn are influencing equipment upgrades and protocol standardization across healthcare systems. Collectively, these multifaceted factors are not only catalyzing growth in the pediatric cardiac tumor diagnostics market but are also reshaping how these rare but critical conditions are approached, detected, and managed worldwide.

SCOPE OF STUDY:

The report analyzes the Pediatric Cardiac Tumor Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Tumor (Primary Cardiac Tumors, Secondary Cardiac Tumors); Type (Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan, Others); End-Use (Hospitals & Clinics, Government Health Department, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • CardioComm Solutions
  • Circle Cardiovascular Imaging
  • Elekta
  • F. Hoffmann-La Roche Ltd
  • Fujifilm Medical Systems
  • GE Healthcare
  • Hitachi Medical Systems
  • Lantheus Medical Imaging
  • Medtronic
  • Philips Healthcare
  • Pie Medical Imaging
  • Samsung Medison
  • Shimadzu Corporation
  • Siemens Healthineers
  • Sophia Genetics
  • Varian Medical Systems

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32502

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pediatric Cardiac Tumor Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Rare Pediatric Cardiac Conditions Throws the Spotlight on Early Diagnostic Tools
    • Advancements in Pediatric Cardiac Imaging Propels Adoption of Non-Invasive Diagnostic Techniques
    • Increasing Availability of Fetal Echocardiography Drives Prenatal Detection of Cardiac Tumors
    • Expansion of Multidisciplinary Pediatric Cardiology Units Strengthens Business Case for Integrated Diagnostics
    • Growing Focus on Early Intervention Expands Addressable Market for Specialized Diagnostic Solutions
    • Development of AI-Based Imaging Analytics Accelerates Diagnostic Accuracy in Pediatric Tumor Cases
    • Rising Incidence of Congenital Heart Defects Generates Demand for Advanced Diagnostic Modalities
    • Enhanced Access to Pediatric Cardiac MRI and CT Scans Spurs Technology Adoption in Tertiary Hospitals
    • Integration of Genetic and Molecular Testing in Cardiac Diagnostics Drives Precision Medicine Strategies
    • Collaborative Research in Pediatric Oncology and Cardiology Throws Spotlight on Cross-Specialty Diagnostics
    • Increased Funding for Rare Disease Research Accelerates Innovation in Pediatric Cardiac Tumor Detection
    • Improved Survival Outcomes from Early Detection Strengthens Business Case for Screening Programs
    • Proliferation of Pediatric Cardiac Centers of Excellence Expands Market for Specialized Diagnostic Services
    • Emergence of Minimally Invasive Biopsy Techniques Propels Growth of Targeted Tumor Diagnostics
    • Standardization of Diagnostic Guidelines by Pediatric Societies Drives Market Formalization
    • Technological Innovations in Portable Ultrasound Devices Drive Access in Rural and Low-Resource Settings
    • Global Burden of Undiagnosed Pediatric Heart Tumors Spurs Investment in Screening Infrastructure
    • Advancement in 3D Echocardiography and Image Fusion Enhances Clinical Confidence in Diagnosis
    • Increasing Use of AI for Tumor Classification and Risk Stratification Strengthens Diagnostic Workflows
    • Regulatory Support for Pediatric Imaging Innovation Sustains Market Momentum for Specialized Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pediatric Cardiac Tumor Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Primary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Primary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Primary Cardiac Tumors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Secondary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Secondary Cardiac Tumors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Secondary Cardiac Tumors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Echocardiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Computed Tomography Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Computed Tomography Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Computed Tomography Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Government Health Department by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Government Health Department by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Government Health Department by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Pediatric Cardiac Tumor Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Pediatric Cardiac Tumor Diagnostics by Tumor - Primary Cardiac Tumors and Secondary Cardiac Tumors Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Tumor - Percentage Breakdown of Value Sales for Primary Cardiac Tumors and Secondary Cardiac Tumors for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Pediatric Cardiac Tumor Diagnostics by Type - Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by Type - Percentage Breakdown of Value Sales for Echocardiography, Magnetic Resonance Imaging, Computed Tomography Scan and Other Types for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Pediatric Cardiac Tumor Diagnostics by End-Use - Hospitals & Clinics, Government Health Department and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Pediatric Cardiac Tumor Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Government Health Department and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!